Search the Newsreel

Lightwave Logic, Inc. Announces Timing of Second Quarter 2026 Financial Results and Business Update Call

Lightwave Logic, Inc. announced it will release its second quarter 2026 financial results after market close on Tuesday, August 11, 2026. The company will also host a business update conference call and webcast on the same day to discuss the results and provide an …

VisionWave files trademark application for AI platform

VisionWave Holdings Inc. has filed an international trademark application for its "VISIONWAVE STRATUM" platform under the Madrid Protocol, covering software and Software-as-a-Service technologies including AI, defense, robotics, and autonomous systems. The application targets the European Union, the United Kingdom, Israel, and the United Arab …

D-Wave Spikes 11% on Nasdaq Verafin Deal, IonQ Gains 9% After SkyWater Buyout, Rigetti Rises 7%

Quantum computing stocks saw significant gains today, with D-Wave Quantum surging 11% following a collaboration announcement with Nasdaq Verafin for fraud detection. IonQ jumped 9% after finalizing its $1.8 billion acquisition of SkyWater Technology, aiming to build a vertically integrated U.S. quantum supply chain. …

D-Wave Quantum faces market volatility despite record bookings and AT&T partnership.

D-Wave Quantum Inc. is experiencing market volatility despite strong commercial progress, including record bookings and an expanded partnership with AT&T. The company faces challenges such as low near-term revenue projections of $43 million for 2026, a high market capitalization of $6.64 billion, intense competition, …

VisionWave (Nasdaq: VWAV) Strengthens Global IP Portfolio and Commercialization Path with International Trademark Filing for STRATUM AI Platform

VisionWave (Nasdaq: VWAV) has filed an international trademark application under the Madrid Protocol for its VISIONWAVE STRATUM AI platform, targeting key international markets including the EU, UK, Israel, and UAE. This strategic move aims to expand IP protection and commercialization opportunities for its specialized …

D-Wave and Nasdaq Verafin Announce Agreement for Quantum Computing Application Development

D-Wave and Nasdaq Verafin have partnered to explore the use of quantum computing for enhanced financial crime detection. This collaboration involves a proof-of-concept project evaluating D-Wave's annealing quantum technology to identify complex patterns in financial data. The initiative aims to develop predictive models for …

Nasdaq Verafin to explore D-Wave quantum technology for financial crime detection (QBTS:NASDAQ)

D-Wave Quantum Inc. (QBTS) and Nasdaq Verafin have announced a partnership to explore the application of quantum computing in financial crime detection. This collaboration aims to leverage quantum technology to combat complex fraud schemes, starting with a proof-of-concept development and potentially expanding to pilot …

D-Wave Quantum and Nasdaq Verafin to Pilot Quantum-Hybrid PoC for Financial Crime Detection

D-Wave Quantum has announced a collaboration with Nasdaq Verafin to develop a quantum-hybrid proof-of-concept aimed at improving the detection of financial crimes such as fraud, scams, and money laundering. This pilot project will utilize D-Wave's annealing quantum technology to analyze extensive data signals, enhancing …

Lightwave Logic Sets Aug. 11 Update on Polymers for Faster Data

Lightwave Logic (NASDAQ:LWLG) announced it will host its Second Quarter 2026 Financial Results and Business Update Call on Tuesday, August 11, 2026, at 8:30 a.m. Eastern Time. The call will be webcast live on the company's website and will include a question-and-answer session for …

Wave Life Sciences (WVE) Is Down 5.2% After Wider Q2 Losses And RNA Editing Updates - What's Changed

Wave Life Sciences reported wider Q2 2026 losses of US$69.36 million and lower sales of US$2.27 million, causing its stock to drop 5.2%. Despite the financial setbacks, the company highlighted positive progress in its RNA editing and RNAi programs, particularly for its AATD therapy …

Wave Life Sciences: Obesity Drug Advances To Phase 2 With Potential For Fat Loss Without Muscle Loss

Wave Life Sciences has initiated Phase 2a of its INLIGHT clinical trial for WVE-007, an investigational obesity treatment designed to reduce body fat while preserving muscle mass. This drug aims to offer a differentiated approach compared to existing incretin-based medicines, with potential for less …

SANUWAVE Health, Inc. Revenue Breakdown – NASDAQ:SNWV

SANUWAVE Health, Inc. (NASDAQ: SNWV) generated $44.05 million USD in revenue last year. The largest portion, $25.80 million USD, came from its Consumable, Parts, and Accessories segment, an increase from the previous year. The United States was the primary contributor to this revenue, accounting …

Enterprise value to EBIT forward of K Wave Media, Ltd. – NASDAQ:KWMWW

The article focuses on the enterprise value to EBIT forward for K Wave Media, Ltd. (NASDAQ:KWMWW). It highlights the financial metric for the company, accessible through TradingView. The content is primarily a listing of navigation and legal disclaimers rather than a detailed financial analysis.

Eco Wave Power Global AB (publ) Revenue Breakdown – NASDAQ:WAVE

This article provides a brief overview of Eco Wave Power Global AB (publ)'s revenue breakdown. Last year, the company generated $0.00 in total revenue, with its top segment, Feasibility Studies, contributing $38,000. All of this revenue came from South Africa.

Price to book forward of D-Wave Quantum Inc. – XETR:RQ0

This article displays financial information for D-Wave Quantum Inc. (XETR:RQ0), specifically its Price to Book Forward value. It is presented on the TradingView platform, noting the market status as closed with no current trades. The content primarily shows the header and navigation elements of …

Lightwave Logic(LWLG) Stock Options Chain | Quotes & News

This article provides access to the stock options chain, quotes, and news for Lightwave Logic (LWLG). It serves as a resource for investors interested in the company's financial performance and market activity.

K Wave Media, Ltd. Revenue Breakdown – NASDAQ:KWM

The article provides a revenue breakdown for K Wave Media, Ltd. (NASDAQ: KWM). It details the financial overview, statements, statistics, dividends, earnings, segments, and regional performance of the company. The content also highlights the various data sources used, such as ICE Data Services and …

Eco Wave Power Global AB (publ) (WAVE) Valuation: PE, PB & Fair Value Analysis

Eco Wave Power Global AB (publ) (WAVE) has a current valuation score of 9.76, placing it 3rd out of 63 in the Electric Utilities & IPPs industry. The company's P/E ratio is -11.18, significantly below its recent high and above its recent low. However, …

WAVE Life Sciences (NASDAQ:WVE) Announces Quarterly Earnings Results

2 Quantum Stocks Expected to Deliver 50%+ Earnings Growth Next Week

Astra Microwave Products shares hit record high on bagging order worth ₹2,205 crore; everything investors need to know

Wave Life Sciences (WVE) Stock Sinks As Losses Deepen And Revenue Dries Up

Wave Life Sciences (WVE) saw its stock drop by 4.3% following Q2 2026 earnings that revealed a widening net loss of US$69.4 million and a significant revenue decline of 73.9% year-over-year. Despite the company's reliance on its PRISM platform for RNA medicines and management's …

Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript

Wave Life Sciences (WVE) reported Q2 2026 earnings, detailing progress in its RNAi and RNA editing pipelines, particularly for obesity (WVE-007) and liver disease (WVE-006, WVE-008). The company highlighted WVE-007's potential for fat loss without muscle degradation and announced an FDA meeting to discuss …

Sanuwave Health to Host Q2 2026 Financial Results Conference Call on August 7

EDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 7, 2026, at 8:30 AM (ET) to present …

Earnings Flash (WVE) Wave Life Sciences Ltd. Reports Q2 Revenue $2.3M, Vs. FactSet Est of $7.4M

Wave Life Sciences Ltd. (WVE) announced its Q2 revenue of $2.3 million, falling significantly short of the FactSet estimate of $7.4 million. This earnings flash indicates a substantial miss on revenue expectations for the company.

KWM|K Wave Media Ord Shs|Price:0.085|Chg%:-0.019

This article provides detailed market data for K Wave Media Ord Shs (KWM), including its current price, market trends, key financial figures, and technical indicators. The stock closed at $0.102, up 35.94%, with a market cap of $7.62 million. Technical indicators show a strong …

K Wave Media announces 1-for-30 reverse stock split

K Wave Media Ltd. announced a 1-for-30 reverse stock split of its ordinary shares, effective August 3, 2026. This action, approved by the Board and shareholders, aims to increase the per-share trading price to maintain compliance with Nasdaq's minimum bid price requirement. The split …

Every 30 K Wave Media shares will become one as trading begins Aug. 3

K Wave Media (Nasdaq: KWM) announced a 1-for-30 reverse stock split, effective August 3, 2026, aimed at increasing its per-share trading price to maintain compliance with Nasdaq’s minimum bid price requirement. The split will reduce outstanding shares from 78,514,509 while proportionally increasing per-share value, …

Wave Life Flat on Q2 Figures

Wave Life Sciences Ltd. announced its financial results for the second quarter ended June 30, 2026, highlighting disciplined execution across its pipeline. CEO Paul Bolno discussed progress in its INLIGHT trial for obesity with WVE-007, aiming to demonstrate its potential for fat loss and …

WVE Looks 35.5% Overvalued on GF Value™

Wave Life Sciences Ltd (NASDAQ: WVE) is considered 35.5% overvalued according to GuruFocus' GF Value™ metric, despite its Price-to-Sales ratio being below its historical median. The company reported a significant revenue decline and continued losses in Q2 2026, though it has strong financial strength …

Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates

Wave Life Sciences (WVE) reported a Q2 loss of $0.34 per share, missing the Zacks Consensus Estimate of a $0.31 loss. The company also posted revenues of $2.27 million, falling short of the consensus estimate by 73.48%. Despite these misses, the estimate revisions trend …

Wave Life Sciences Ltd earnings missed by $0.04, revenue fell short of estimates

Wave Life Sciences Ltd (NASDAQ: WVE) reported a second-quarter EPS of $-0.340, missing analyst estimates by $0.04, and revenue of $2.3M, which fell short of the $7.65M consensus. The company's stock has seen a significant decline over the past 3 and 12 months, with …

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Wave Life Sciences (Nasdaq: WVE) announced its second quarter 2026 financial results, highlighting significant progress in its clinical pipeline. Key updates include ongoing dosing in a Phase 2a trial for WVE-007 for obesity, with plans to initiate Phase 2 combination trials later in 2026. …

Wave Life Sciences Ltd. Q2 2026: Revenue $2.3M, EPS $(0.34) — 10-Q Summary

Wave Life Sciences Ltd. reported Q2 2026 results with $2.3 million in revenue and a diluted loss per share of $0.34. This reflects a decrease in collaboration revenue and continued investment in research and development. Despite the quarterly decline, six-month revenue increased significantly due …

Wave Life Sciences: Q2 Earnings Snapshot

Wave Life Sciences Pte. Ltd. (WVE) reported a Q2 loss of $69.4 million, or 34 cents per share, which was worse than Wall Street's expectation of a 31-cent loss per share. The biopharmaceutical company also posted revenue of $2.3 million, falling short of the …

VisionWave Extends Belrise Condition and Closing Deadlines to Dec 31, 2026 Under Share Purchase

VisionWave has extended the Belrise Long-Stop Date and Outside Closing Date to December 31, 2026, by entering into a side letter with Matania Moskovich and C.M. Composite Materials. This amendment to their Investment and Share Purchase Agreement allows VisionWave to terminate the deal without …